Praxis Precision Medicines, Inc.
PRAX
$311.71
$7.332.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 1,349.13% | -35.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 1,349.13% | -35.47% |
| Cost of Revenue | 57.10% | 131.13% | 125.34% | 206.11% | 142.65% |
| Gross Profit | -58.25% | -134.20% | -129.00% | -173.18% | -147.61% |
| SG&A Expenses | -17.66% | 23.39% | -9.20% | 52.33% | 74.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.14% | 101.00% | 76.59% | 152.18% | 119.89% |
| Operating Income | -37.87% | -102.91% | -78.41% | -130.01% | -122.74% |
| Income Before Tax | -42.43% | -117.67% | -75.20% | -118.32% | -110.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -42.43% | -117.67% | -75.20% | -118.32% | -110.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.43% | -117.67% | -75.20% | -118.32% | -110.74% |
| EBIT | -37.87% | -102.91% | -78.41% | -130.01% | -122.74% |
| EBITDA | -38.06% | -103.37% | -78.77% | -130.76% | -123.34% |
| EPS Basic | -22.38% | -90.80% | -15.70% | 0.99% | -0.87% |
| Normalized Basic EPS | -22.39% | -90.81% | -17.49% | -1.35% | -0.87% |
| EPS Diluted | -22.38% | -90.80% | -15.70% | 0.99% | -0.87% |
| Normalized Diluted EPS | -22.39% | -90.81% | -17.49% | -1.35% | -0.87% |
| Average Basic Shares Outstanding | 16.38% | 14.08% | 51.43% | 120.51% | 108.91% |
| Average Diluted Shares Outstanding | 16.38% | 14.08% | 51.43% | 120.51% | 108.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |